Grants and Contributions:
Title:
Development of Innovative Nanocrystalline Biomaterials to Prevent and Treat Implant Infections.
Agreement Number:
977564
Agreement Value:
$105,177.00
Agreement Date:
Jul 1, 2021 - Mar 31, 2023
Description:
This project will allow the determination of the parameters to set up a continuous, automated scale-up production of the firm's product for transfer to a large Canadian CMO.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H3H 2L3
Reference Number:
172-2021-2022-Q3-977564
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
721466290
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 151 days.
Amendment Date
Sep 21, 2022
Recipient's Legal Name:
INViCare Inc.
Federal Riding Name:
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number:
24077
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254
Amendments: